Baillie Gifford & CO 10x Genomics, Inc. Transaction History

Baillie Gifford & CO

  • $131 Billion
  • Q3 2024

A detailed history of Baillie Gifford & CO transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Baillie Gifford & CO holds 40,378 shares of TXG stock, worth $592,345. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40,378
Previous 2,742,153 98.53%
Holding current value
$592,345
Previous $53.3 Million 98.29%
% of portfolio
0.0%
Previous 0.04%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
SELL
$15.71 - $23.49 $42.4 Million - $63.5 Million
-2,701,775 Reduced 98.53%
40,378 $911,000
Q2 2024

Jul 25, 2024
SELL
$19.45 - $37.37 $91.1 Million - $175 Million
-4,682,613 Reduced 63.07%
2,742,153 $53.3 Million
Q1 2024

May 01, 2024
SELL
$36.08 - $54.3 $17.9 Million - $26.9 Million
-495,210 Reduced 6.25%
7,424,766 $279 Million
Q4 2023

Jan 26, 2024
SELL
$34.32 - $57.55 $14.4 Million - $24.2 Million
-420,922 Reduced 5.05%
7,919,976 $443 Million
Q3 2023

Nov 13, 2023
SELL
$40.86 - $62.98 $6.67 Million - $10.3 Million
-163,349 Reduced 1.92%
8,340,898 $344 Million
Q2 2023

Jul 28, 2023
SELL
$50.96 - $58.72 $12.7 Million - $14.7 Million
-249,740 Reduced 2.85%
8,504,247 $475 Million
Q1 2023

May 03, 2023
BUY
$35.33 - $55.79 $5.36 Million - $8.47 Million
151,752 Added 1.76%
8,753,987 $488 Million
Q4 2022

Jan 24, 2023
BUY
$24.4 - $41.3 $3.88 Million - $6.56 Million
158,847 Added 1.88%
8,602,235 $313 Million
Q3 2022

Oct 27, 2022
BUY
$28.48 - $52.59 $1.83 Million - $3.39 Million
64,417 Added 0.77%
8,443,388 $240 Million
Q2 2022

Aug 08, 2022
BUY
$36.95 - $82.41 $37.8 Million - $84.3 Million
1,023,207 Added 13.91%
8,378,971 $379 Million
Q1 2022

May 05, 2022
BUY
$55.7 - $145.79 $26.6 Million - $69.6 Million
477,387 Added 6.94%
7,355,764 $560 Million
Q4 2021

Jan 20, 2022
BUY
$135.05 - $182.59 $180 Million - $244 Million
1,335,752 Added 24.1%
6,878,377 $1.02 Billion
Q3 2021

Oct 19, 2021
BUY
$145.58 - $192.14 $74.5 Million - $98.3 Million
511,629 Added 10.17%
5,542,625 $807 Million
Q2 2021

Aug 02, 2021
BUY
$134.22 - $202.37 $488 Million - $736 Million
3,634,870 Added 260.35%
5,030,996 $985 Million
Q1 2021

May 06, 2021
BUY
$140.25 - $196.86 $87.1 Million - $122 Million
621,106 Added 80.14%
1,396,126 $253 Million
Q4 2020

Feb 10, 2021
BUY
$126.47 - $163.7 $33.3 Million - $43.1 Million
263,573 Added 51.53%
775,020 $110 Million
Q3 2020

Nov 12, 2020
BUY
$87.44 - $125.0 $44.3 Million - $63.4 Million
507,150 Added 11802.42%
511,447 $63.8 Million
Q2 2020

Aug 12, 2020
BUY
$58.39 - $89.31 $158,120 - $241,851
2,708 Added 170.42%
4,297 $384,000
Q1 2020

May 08, 2020
BUY
$51.57 - $106.62 $81,944 - $169,419
1,589 New
1,589 $99,000

Others Institutions Holding TXG

# of Institutions
291
Shares Held
94.7M
Call Options Held
263K
Put Options Held
85.1K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.39B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Baillie Gifford & CO Portfolio

Follow Baillie Gifford & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email